Forget about a console or controls, CNBC's Julia Boorstin takes a look at cutting edge technology that will transform video games and make them more immersive in 25 years.» Read More
Andres Garcia-Amaya, JPMorgan Funds; Peter Sorrentino, Huntington Asset Advisors; and CNBC's Rick Santelli, provide their strategies on trading the markets now.
Japan is sitting on a debt time bomb and recent moves to push the central bank to target inflation have made it more likely the bomb will explode in the next 24 months, hedge fund manager Kyle Bass told CNBC.
As CNBC’s Herb Greenberg delivers his list of high-flying stocks that deserve a caution flag, Jim Cramer makes an unscheduled appearance to take issue with some of the names. (7:05)
CNBC's David Faber talks with Kyle Bass, Hayman Capital Management, about his critical view of the Japanese yen; and explains why he is now investing in subprime bonds. (9:50)
CNBC's Brian Shactman talks with Neil Weinberg, American Banker editor-in-chief, about whether the retail investor should get into the markets now; and whether Lance Armstrong will be able to restore his brand after admitting he used performance enhancing drugs on an Oprah interview.
The FMHR traders reveal their final trades of the hour. (0:49)
CNBC's Simon Hobbs reports on all the market moving events in Europe today.
China GDP beats estimates; GE says it's seeing growth in China & reports strong Q4, with the "Squawk on the Street" team.
James Gorman, chairman & CEO of Morgan Stanley, says individual investors have left money in while waiting for good ideas.
Morgan Stanley Chairman & CEO Morgan Stanley tells “Squawk Box” why he thinks stocks will be moving higher. (1:50)
Barry Knapp, Barclays, and Rebecca Patterson, Bessemer Trust, discuss where stock prices and the economy are headed.
CNBC's Kelly Evans tells you what the markets will be watching as we approach the start of trading in the U.S.
Phil Orlando, Federated Investors, weighs in on the markets, politics and more.
Discussing what's holding back growth in the markets, with Dean Baker, Center For Economic & Policy Research; Jim Pethokoukis, American Enterprise Institute; and Stephen Weiss, Short Hills Capital.
Mad Money host Jim Cramer shares his final thoughts of the day.
Ironwood Pharmaceuticals recently launched a drug called Linzess, and the company also reported an EPS loss; and Mad Money host Jim Cramer answers viewers' investment questions.
Mad Money host Jim Cramer weighs in on the action in shares of Herbalife over the last year.
The S&P 500 could take a swing at 1500 in the near future if earnings news doesn't trip it up.
The Affordable Care Act will require companies that employ more than 50 full-time workers will either need to provide their employees with health coverage or pay a penalty. Mad Money host Jim Cramer, weighs in.
Mad Money host Jim Cramer discusses whether it's time to err on the side of caution in investing in Boeing.